This newly created position will be responsible for participating in a variety of key finance and accounting activities including month-end close, clinical trial accrual accounting, financial reporting, documentation and monitoring of policies and internal controls for compliance with Sarbanes-Oxley and other administrative functions.

Facilitate communication with SOX third party consultants and external auditors

Position Requirements:

Bachelor’s degree in accounting or equivalent

CPA certificate is preferred

Four to six years work experience; some public accounting experience is preferred

Strong technical accounting background

Strong analytical and problem-solving skills

Combination of public accounting / private industry experience is ideal

Advanced Excel skills

Great Plains Dynamics experience preferred

Strong verbal and written communication skills

Personal Competencies:

Rational, critical thinking capability

Self-motivated, ability to work independently

Team player, intensely committed to organizational success in a highly dynamic environment

Effective interpersonal skills, including both written and oral communication skills

Ability to multitask, prioritize, and function in a fast-paced entrepreneurial environment

Willingness to learn new concepts and technologies

Regulus Therapeutics Inc. (Nasdaq: RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs. Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a well-balanced microRNA therapeutics pipeline complemented by a rich intellectual property estate to retain its leadership in the microRNA field. Regulus is advancing several programs in renal, hepatic and central nervous systems diseases.

Regulus is located in La Jolla, California and is led by a seasoned executive team experienced in corporate management, business, science, drug discovery and development. Regulus' scientific advisory board consists of world-class scientists and some of the foremost authorities in the field of microRNA research.